SCHEMBL5779020

SCHEMBL5779020

CCOC(=O)c1c[nH]nc1Cc1cccc(OC)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGES O14684 1/20 0.48
ALOX5 P09917 1/20 0.48
KDM4E B2RXH2 5/20 0.48
ALDH1A1 P00352 4/20 0.48
SLC26A6 Q9BXS9 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
KDM4C Q9H3R0 1/20 0.45
KDM5B Q9UGL1 1/20 0.45
MAPT P10636 3/20 0.44
HPGD P15428 2/20 0.44
LMNA P02545 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
POLB P06746 1/20 0.43
MMP1 P03956 2/20 0.43
MMP2 P08253 2/20 0.43
MMP9 P14780 2/20 0.43
MMP12 P39900 2/20 0.43
TP53 P04637 2/20 0.43
MTNR1A P48039 1/20 0.42
MTNR1B P49286 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5820787 0.84 PDE3B (0.42) ALDH1A1SMN1; SMN2MAPTPDE3BPDE3A
SCHEMBL5779014 0.84 PDE3B (0.49) PTGESALOX5KDM4ESLC26A6SMN1; SMN2
SCHEMBL5778710 0.83 SMN1; SMN2 (0.52) KDM4EALDH1A1SMN1; SMN2MAPTTDP1
SCHEMBL5055900 0.82 KDM4E (0.48) KDM4EALDH1A1SMN1; SMN2MAPTHPGD
SCHEMBL5820742 0.81 KDM4E (0.44) KDM4EALDH1A1SMN1; SMN2MAPTPOLB
SCHEMBL16974053 0.78 KDM4E (0.58) KDM4EALDH1A1SMN1; SMN2MAPTHPGD
SCHEMBL5744663 0.77 DPP4 (0.65) KDM4EALDH1A1SMN1; SMN2MAPTHPGD
SCHEMBL22272865 0.77 PTGES (0.53) PTGESALOX5KDM4EALDH1A1SLC26A6
SCHEMBL4717597 0.77 ALDH1A1 (0.52) KDM4EALDH1A1SMN1; SMN2MAPTHPGD
SCHEMBL13494052 0.76 ALDH1A1 (0.49) PTGESALOX5KDM4EALDH1A1SLC26A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1678181-A2 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS, INC. (US) 2006-07-12 EP disclosed
WO-2005042534-A2 A2B ADENOSINE RECEPTOR ANTAGONISTS CV THERAPEUTICS, INC. (US) 2005-05-12 WO disclosed